Related Experiment Video
Updated: Sep 8, 2025

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Advancing Precision Medicine in Inflammatory Skin Disease
Michelle Yuan1,2, Jinwoo Lee3, Mark Taylor1
1Department of Dermatology, University of California, San Francisco, 1701 Divisadero Street, 3rd Floor, San Francisco, CA, 94115, USA.
Precision medicine tailors chronic inflammatory skin disease treatment to individual molecular biology, moving beyond trial-and-error. This approach promises improved patient outcomes and more efficient dermatologic care.
Area of Science:
- Dermatology
- Immunology
- Genomics
Background:
- Targeted immunomodulatory therapies have advanced chronic inflammatory skin disease treatment.
- Current treatment selection is often empirical, lacking personalization based on individual disease biology.
- This leads to suboptimal clinical outcomes and inefficient care delivery.
Purpose of the Study:
- To outline how precision medicine can transform diagnosis and treatment selection in dermatology.
- To highlight key clinical contexts where precision approaches are most impactful.
- To advocate for the integration of precision medicine into dermatologic practice.
Main Methods:
- Review of current therapeutic strategies and their limitations.
- Discussion of precision medicine principles applied to skin diseases.
- Highlighting advanced techniques like single-cell RNA sequencing and spatial transcriptomics.
Main Results:
- Precision medicine enables tailored diagnosis and treatment based on molecular and cellular features.
- Advanced techniques offer refined disease classification and prediction of drug response.
- Potential benefits include reduced therapeutic inefficiency and improved patient outcomes.
Conclusions:
- Precision medicine offers a transformative solution to the heterogeneity of chronic inflammatory skin diseases.
- Despite challenges like cost and biomarker validation, benefits outweigh drawbacks.
- Expanded research, funding, and scalable diagnostics are crucial for widespread adoption in dermatology.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

